1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Overactive Bladder (OAB): new trials by email Literature Review of Overactive Bladder (OAB) trials Research Report on Overactive Bladder (OAB)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB) Mirabegron, Placebo - Overactive Bladder (OAB), Pharmacokinetics of Mirabegron | Phase 3 | Terminated | Astellas Pharma Global Development, Inc. | 26 | 2021-03-15 | 2024-11-14 |
Urinary Bladder, Overactive (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Lower Urinary Tract Symptoms (1) · Male Urogenital Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Urinary Bladder Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1) · Urological Manifestations (1)
mirabegron (1)
Astellas Pharma Global Development, Inc. (1)
Belgium (1) · France (1) · Malaysia (1) · Norway (1) · Philippines (1) · Russia (1) · South Korea (1) · Turkey (Türkiye) (1) · Ukraine (1) · United Kingdom (1)
2016 (1)